Bronchain Odile, Jdey Wael, Caraty Laetitia, Ciapa Brigitte
Paris-Saclay Institute of Neuroscience, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Orsay, France.
Int J Dev Biol. 2017;61(6-7):451-457. doi: 10.1387/ijdb.170053bc.
Mitotic arrest deficient 2 (Mad2) belongs to the spindle assembly checkpoint (SAC), a mechanism that blocks progression of the cell cycle until microtubule attachment to kinetochores is complete. It has been found to be involved in the resistance of cancer cells to "anti-mitotic" drugs such as paclitaxel. Mad2 controls meiotic progression, but its role during sea urchin development had never been investigated. Furthermore, the existence of a SAC in this species had never been proved. The present data show that a Mad2 protein, highly homologous to that of humans, is expressed in this species. Mad2 expression increases during development, becoming confined to the endomesoderm at gastrula stages. The level of Mad2 expression is enhanced in embryos that do not gastrulate after treatment with anti-mitotic drugs, lithium or inhibition of the ERK pathway. Mis-aligned and lagging chromosomes were induced after injection of an anti-Mad2 antibody or a Mad2 morpholino. Our results point to the role of a non-canonical SAC involving Mad2 in the control of mitotic divisions of the sea urchin embryo.
有丝分裂阻滞缺陷蛋白2(Mad2)属于纺锤体组装检验点(SAC),这是一种在微管与动粒完全附着之前阻止细胞周期进程的机制。人们发现它与癌细胞对紫杉醇等“抗有丝分裂”药物的抗性有关。Mad2控制减数分裂进程,但其在海胆发育过程中的作用从未被研究过。此外,该物种中SAC的存在也从未得到证实。目前的数据表明,该物种中表达了一种与人类高度同源的Mad2蛋白。Mad2的表达在发育过程中增加,在原肠胚阶段局限于内胚层。在用抗有丝分裂药物、锂或抑制ERK途径处理后不能形成原肠胚的胚胎中,Mad2的表达水平增强。注射抗Mad2抗体或Mad2吗啉代寡核苷酸后会诱导染色体排列错误和滞后。我们的结果表明,涉及Mad2的非经典SAC在控制海胆胚胎有丝分裂中起作用。